CervoMed Statistics

Total Valuation

CervoMed has a market cap or net worth of $103.75 million. The enterprise value is $51.28 million.

Market Cap	103.75M
Enterprise Value	51.28M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

CervoMed has 8.25 million shares outstanding. The number of shares has increased by 35.96% in one year.

Shares Outstanding	8.25M
Shares Change (YoY)	+35.96%
Shares Change (QoQ)	+41.04%
Owned by Insiders (%)	35.20%
Owned by Institutions (%)	24.41%
Float	3.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.85
Forward PS	19.77
PB Ratio	2.04
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.73

Current Ratio	14.73
Quick Ratio	14.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	$1.21M
Profits Per Employee	-$630,410
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+19.71%
50-Day Moving Average	15.21
200-Day Moving Average	16.85
Relative Strength Index (RSI)	40.92
Average Volume (20 Days)	76,413

Short Selling Information

The latest short interest is 1.18 million, so 14.30% of the outstanding shares have been sold short.

Short Interest	1.18M
Short Previous Month	1.15M
Short % of Shares Out	14.30%
Short % of Float	30.33%
Short Ratio (days to cover)	12.40

Income Statement

In the last 12 months, CervoMed had revenue of $9.65 million and -$5.04 million in losses. Loss per share was -$0.82.

Revenue	9.65M
Gross Profit	1.21M
Operating Income	-9.95M
Pretax Income	-5.04M
Net Income	-5.04M
EBITDA	n/a
EBIT	-9.95M
Loss Per Share	-$0.82

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	45.09M
Total Debt	n/a
Net Cash	50.90M
Net Cash Per Share	$6.17
Equity (Book Value)	49.98M
Book Value Per Share	6.06
Working Capital	44.11M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.63M
Capital Expenditures	n/a
Free Cash Flow	-7.63M
FCF Per Share	-$0.92

Full Cash Flow Statement

Margins

Gross margin is 12.58%, with operating and profit margins of -103.03% and -52.24%.

Gross Margin	12.58%
Operating Margin	-103.03%
Pretax Margin	-52.24%
Profit Margin	-52.24%
EBITDA Margin	n/a
EBIT Margin	-103.03%
FCF Margin	-35.85%

Dividends & Yields

CervoMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.96%
Shareholder Yield	-35.96%
Earnings Yield	-4.94%
FCF Yield	-7.47%

Analyst Forecast

The average price target for CervoMed is $57.60, which is 358.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$57.60
Price Target Difference	358.23%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	38.70%
EPS Growth Forecast (5Y)	70.71%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CervoMed has an Altman Z-Score of 15.64 and a Piotroski F-Score of 2.

Altman Z-Score	15.64
Piotroski F-Score	2